Additional deletion of Pten or Rbl2 and stabilisation/over-expression of MYC have been shown to further accelerate tumorigenesis and promote metastasis in these SCLC mouse models initiated by the loss of Rb1 and p53 [146–148]. Here, TP53 is linked to small cell lung carcinoma.